{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:08:32Z","timestamp":1780632512098,"version":"3.54.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1636,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to evaluate the clinical characteristics, echocardiographic measurements, medical treatment, pregnancy outcomes, and the 6 month follow-up outcomes among patients with peripartum cardiomyopathy (PPCM) in Iraq.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Data were collected prospectively at cardio-maternal clinic in Baghdad Heart Center, using case report form for the EORP-PPCM registry from January 2015 to November 2020. Six month follow-up was performed either by attendance of patients or by phone contact. A total of 64 PPCM patients were enrolled with a mean age of 32.1 \u00b1 6.8 years. Diagnosis in 35 (54.7%) women was made in the post-partum period. There was a history of previous PPCM in 9 (14%), coexisting hypertension with the current pregnancy in 30 (51.7%), cholelithiasis in 5 (7.8%), and cancer in 3 (4.7%). Baseline mean left ventricular ejection fraction (LVEF) was 34.7 \u00b1 8.1%, significantly higher than that reported globally (31 \u00b1 10%) (P-value 0.011), and 26 (40.6%) of our patients had LVEF of \u226434%. Baseline mean global longitudinal strain (GLS) for 26 (40.6%) patients was \u22129.4 \u00b1 4.1%. Baseline mean left ventricular end-diastolic and end-systolic dimensions were 61.2 \u00b1 8.5 and 50.6 \u00b1 10.2 mm, respectively. At 6 month follow-up, 11 (36.7%) women recovered their LVEF, lower than global data (46%) but higher than that in the Middle East (25%) with P-value 0.241 and 0.919, respectively. The mean LVEF was 44.5 \u00b1 11.9%, and the mean GLS for 15 (23.4%) of patients was \u221213.4 \u00b1 5.3%, including 5 (33.3%) with the range of \u221218.6% to \u221217%. Bromocriptine was the least used drug in 4 (8.2%) vs. globally reported (15%) (P-value 0.188). Thrombo-embolic events and maternal death were reported in 2 (4.1%) and 3 (4.7%) cases, respectively, within 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Around half of our PPCM patients were diagnosed at post-partum period with impaired initial LVEF and GLS, and one-third had early LVEF recovery at 6 month follow-up, higher than that in the Middle East but lower than the globally reported figure in the EORP-PPCM registry. Limited use of bromocriptine might explain the later finding. The co-morbid diseases in our setting were hypertension and cholelithiasis. Interestingly, the comparable ratios of neonatal and maternal mortalities in our study to that of the EORP-PPCM registry were found less than the Middle East figures. Bromocriptine needs to be considered in Middle East countries, including Iraq, which may be the key to improving LVEF recovery and perhaps reducing maternal mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13502","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T21:09:08Z","timestamp":1624914548000},"page":"4048-4054","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Peripartum Cardiomyopathy in Iraq: Initial Registry-Based Data and 6 Month Outcomes"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-4966","authenticated-orcid":false,"given":"Hasan Ali","family":"Farhan","sequence":"first","affiliation":[{"name":"Scientific Council of Cardiology, Iraqi Board for Medical Specializations , Baghdad ,","place":["Iraq"]},{"name":"Baghdad Heart Center, Baghdad Teaching Hospital, Medical City , Baghdad ,","place":["Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-7359","authenticated-orcid":false,"given":"Israa Fadhil","family":"Yaseen","sequence":"additional","affiliation":[{"name":"Baghdad Heart Center, Baghdad Teaching Hospital, Medical City , Baghdad ,","place":["Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"2026012114230968500_ehf213502-bib-0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-817667-2.00009-8","volume-title":"Peripartum Cardiomyopathy: From Pathophysiology to Management","author":"Farhan","year":"2021"},{"key":"2026012114230968500_ehf213502-bib-0002","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ejhf.780","article-title":"Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM","volume":"19","author":"Sliwa","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114230968500_ehf213502-bib-0003","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/eurheartj\/ehaa455","article-title":"Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry","volume":"41","author":"Sliwa","year":"2020","journal-title":"Eur Heart J"},{"key":"2026012114230968500_ehf213502-bib-0004","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ejhf.808","article-title":"Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy","volume":"19","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114230968500_ehf213502-bib-0005","first-page":"145","article-title":"Scompenso cardiaco e calcolosi biliare [Heart failure and cholelithiasis]","volume":"97","author":"Bindi","year":"2006","journal-title":"Recenti Prog Med"},{"key":"2026012114230968500_ehf213502-bib-0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076448","article-title":"Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study","volume":"8","author":"Olaiya","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012114230968500_ehf213502-bib-0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15430-5","article-title":"The relation between gallstone disease and cardiovascular disease","volume":"7","author":"Fan","year":"2017","journal-title":"Sci Rep"},{"key":"2026012114230968500_ehf213502-bib-0008","first-page":"196","article-title":"Increased cancer prevalence in peripartum cardiomyopathy","volume":"1","author":"Pfeffer","year":"2019","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"2026012114230968500_ehf213502-bib-0009","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1002\/ehf2.13030","article-title":"Clinical presentation and outcomes of peripartum cardiomyopathy in the Middle East: a cohort from seven Arab countries","volume":"7","author":"Salam","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114230968500_ehf213502-bib-0010","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/echo.13277","article-title":"Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy","volume":"33","author":"Briasoulis","year":"2016","journal-title":"Echocardiography"},{"key":"2026012114230968500_ehf213502-bib-0011","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.echo.2019.07.018","article-title":"Global left ventricular strain at presentation is associated with subsequent recovery in patients with peripartum cardiomyopathy","volume":"32","author":"Sugahara","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012114230968500_ehf213502-bib-0012","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(20)31423-6","article-title":"Abnormal global longitudinal strain persists after recovery of peripartum cardiomyopathy","volume":"75","author":"Brener","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012114230968500_ehf213502-bib-0013","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114230968500_ehf213502-bib-0014","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114230968500_ehf213502-bib-0015","volume-title":"Iraq: maternal, newborn, child and adolescent health","author":"World Heart Organization"},{"key":"2026012114230968500_ehf213502-bib-0016","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114230968500_ehf213502-bib-0017","first-page":"8","article-title":"Peripartum cardiomyopathy: a review","volume":"39","author":"Bhattacharyya","year":"2012","journal-title":"Tex Heart Inst J"},{"key":"2026012114230968500_ehf213502-bib-0018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/14767058.2018.1494146","article-title":"Predictors of early and delayed recovery in peripartum cardiomyopathy: a prospective study of 52 patients","volume":"33","author":"Biteker","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026012114230968500_ehf213502-bib-0019","first-page":"362","article-title":"Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy","volume":"32","author":"Li","year":"2016","journal-title":"Can J Cardiol"},{"key":"2026012114230968500_ehf213502-bib-0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/14767058.2017.1317341","article-title":"Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy","volume":"31","author":"Barasa","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026012114230968500_ehf213502-bib-0021","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.jacc.2014.04.014","article-title":"Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use","volume":"63","author":"Pillarisetti","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13502","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/5\/4048\/65567856\/eschf_8_5_4048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/5\/4048\/65567856\/eschf_8_5_4048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:28:57Z","timestamp":1769023737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/5\/4048\/8345933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,6,28]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13502","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10]]},"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"2021-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}